💼 AI Business

Big Pharma's Cynical Bet on Open Protein AI to Escape Google's Grip

Big Pharma hates relying on Google as much as academics do. They're pouring cash into open protein-folding AI—but don't call it altruism.

3D protein structure unfolding with pharmaceutical company logos and open-source code overlay

⚡ Key Takeaways

  • Big Pharma funds OpenFold to avoid Google DeepMind dependency, not pure altruism.
  • OpenFold provides full code and data, countering AlphaFold's restrictions.
  • Skeptics predict pharma will steer open tools toward proprietary gains.

🧠 What's your take on this?

Cast your vote and see what theAIcatchup readers think

Aisha Patel
Written by

Aisha Patel

Former ML engineer turned writer. Covers computer vision and robotics with a practitioner perspective.

Worth sharing?

Get the best AI stories of the week in your inbox — no noise, no spam.

Originally reported by Understanding AI

Stay in the loop

The week's most important stories from theAIcatchup, delivered once a week.